Target intelligence / Profile preview

MicroRNA 1243 (MIR1243)

Target
MIR1243
Molecular classification
Other (non-coding RNA, microRNA)
01

Overview

MicroRNA 1243 (MIR1243, hsa-mir-1243) is annotated as a putative microRNA in humans, identified primarily through high-throughput sequencing techniques. At present, there is no published evidence for functional biological activity, validated gene targets, or disease associations for MIR1243 in the peer-reviewed literature and major microRNA databases. It is classified as a non-coding RNA of the microRNA family, but has not been characterized as a receptor, enzyme, transporter, or established therapeutic target in any context. Its inclusion as a molecular target is likely an error due to lack of validation and characterization, and it should not be considered a bona fide drug target or biomarker at this time. - Note: MIR1243 is not to be confused with functionally established microRNAs (such as miR-125b) that have documented roles in gene regulation, apoptosis, or disease[1][2]. The available evidence suggests that information on MIR1243 is largely limited to sequence annotation, with no reports of clinical, biological, or pharmacological relevance. If you require exhaustive molecular target information, please provide a functionally validated microRNA or gene name.

Other names
hsa-mir-1243MIRN1243MIR1243
02

Mechanism of action

Not applicable

03

Biological functions

No validated or documented specific biological functions
04

Disease associations

No validated or documented disease associations
05

Safety considerations

None known or reported
06

Interacting drugs

None known or reported
07

Biomarkers

None known or reported

Beyond the preview

Go deeper on MicroRNA 1243 (MIR1243).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1243 (MIR1243).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call